Sign in

CIK 0001400118 · <br>Emerging growth company

Sagimet Biosciences Inc.

Sign in to watch
Ticker
SGMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205991472
Phone
(650) 561-8600
Business address
950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
Former names
3-V Biosciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-07-18 Parsey Merdad Director Returned to the company · Stock Option (Right to Buy) −23,216 0
2023-07-18 Parsey Merdad Director Grant or award · Stock Option (Right to Buy) +23,216 23,216
2023-07-18 Parsey Merdad Director Returned to the company · Stock Option (Right to Buy) −23,839 0
2023-07-18 Parsey Merdad Director Grant or award · Stock Option (Right to Buy) +23,839 23,839
2023-07-18 Martins Eduardo Bruno Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −198,132 0
2023-07-18 Martins Eduardo Bruno Chief Medical Officer Grant or award · Stock Option (Right to Buy) +198,132 198,132
2023-07-18 Martins Eduardo Bruno Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −44,009 0
2023-07-18 Martins Eduardo Bruno Chief Medical Officer Grant or award · Stock Option (Right to Buy) +44,009 44,009
2023-07-18 Kemble George Director Returned to the company · Stock Option (Right to Buy) −5,630 0
2023-07-18 Kemble George Director Grant or award · Stock Option (Right to Buy) +5,630 5,630
2023-07-18 Kemble George Director Returned to the company · Stock Option (Right to Buy) −3,179 0
2023-07-18 Kemble George Director Grant or award · Stock Option (Right to Buy) +3,179 3,179
2023-07-18 Kemble George Director Returned to the company · Stock Option (Right to Buy) −7,147 0
2023-07-18 Kemble George Director Grant or award · Stock Option (Right to Buy) +7,147 7,147
2023-07-18 Kemble George Director Returned to the company · Stock Option (Right to Buy) −26,352 0
2023-07-18 Kemble George Director Grant or award · Stock Option (Right to Buy) +26,352 26,352
2023-07-18 Kemble George Director Returned to the company · Stock Option (Right to Buy) −367,824 0
2023-07-18 Kemble George Director Grant or award · Stock Option (Right to Buy) +367,824 367,824
2023-07-18 Kemble George Director Returned to the company · Stock Option (Right to Buy) −46,432 0
2023-07-18 Kemble George Director Grant or award · Stock Option (Right to Buy) +46,432 46,432

Page 9 of 10 · 194 trades